Thrombospondin-4 (TSP4) attracted a lot of attention recently as a result of new functions identified for this matricellular protein in cardiovascular, muscular, and nervous systems. We have previously reported that TSP4 promotes local vascular inflammation in mouse atherosclerosis model. A common variant of TSP4, P387-TSP4, was associated with increased cardiovascular disease risk in human population studies. In a mouse atherosclerosis model, TSP4 had profound effect on accumulation of macrophages in lesions, which prompted us to examine its effects on macrophages, more in detail in this report.
Introduction
Thrombospondin-4 (TSP4) is a matricellular protein, one of the five members of thrombospondin family [1, 2] . TSP4 expression is low in adult tissues but dramatically increases during tissue remodeling and regeneration. High levels of TSP4 have been detected in remodeling and failing hearts [3] [4] [5] [6] [7] , several cancers [8] [9] [10] [11] [12] [13] , and atherosclerotic lesions [14] . Recently, new functions have been ascribed to TSP4 in cardiovascular system [5] [6] [7] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , cancer [8] [9] [10] [11] [12] [24] [25] [26] [27] [28] [29] , and nervous system [30] [31] [32] [33] [34] , but effects of TSP4 on cellular responses and the regulation of TSP4 expression remain poorly understood. For example, with an exception of TGF-beta [25] , stimuli inducing TSP4 expression in tissues remain unknown. Although several cell surface receptors were shown to mediate TSP4 effects [14, 24, 30, 35] , signaling and regulation of intracellular processes by TSP4 have received only limited attention.
Tissue remodeling, inflammation, and angiogenesis often occur simultaneously and are regulated by the same stimuli. We recently reported that TSP4 promotes angiogenesis [24, 25] and vascular inflammation in a mouse atherosclerosis model [14] . These observations suggested that TSP4 may play an important role in regulation of inflammation and inflammatory cell responses. In the present study, we describe effects of TSP4 and its common variant, P387-TSP4, on macrophages. The P387-TSP-4 variant is associated with cardiovascular disease and myocardial infarction [15] [16] [17] [18] [19] [20] [21] [22] and is more active than WT A387-TSP4 in mediating cellular effects [24, [35] [36] [37] . TSP4 production by blood cells has not been reported to date. Here, we report several stimuli that induce or reduce TSP4 production in macrophages. The effect of TSP4 on macrophages has been examined in isolated macrophages and in LPS-induced peritonitis, an in vivo model of acute inflammation.
Macrophages play multiple roles in both the tissue homeostasis and inflammation, e.g., promote the initiation, progression, and healing of tissue injury; facilitate tissue remodeling associated with various pathologies; and participate in initiation and resolution of inflammation in tissues [38, 39] . Macrophages are a heterogeneous cell types with high plasticity and display a variety of phenotypes regulated by external stimuli, including the extracellular matrix [40] . A continuum of phenotypes exists that can be pragmatically divided into pro-inflammatory and tissue repair macrophages. Phenotypic polarization of macrophages is regulated by pro--inflammatory stimuli that include Toll-like receptor (TLR) ligands and IFNγ, which induce proinflammatory phenotypes, and by anti-inflammatory stimuli such as IL4/IL13, immune complexes, the anti-inflammatory cytokines IL-10, and transforming growth factor-β that induce tissue repair phenotypes [41] [42] [43] [44] . Although the effects of microenvironment, including ECM proteins and matricellular proteins specifically, on phenotypic differentiation of macrophages are undeniable, they are still poorly understood. Here, we have uncovered previously unrecognized cellular mechanisms for regulation of phenotypes and functions of macrophages by TSP4 and the P387-TSP4 variant.
Methods and Materials

Animals:
Mice were of the C57BL/6 background. Both genders were used (there were no gender-specific differences). Thbs4 −/− mice were described previously [5, 14, 24, 25, 45] . Control wild-type (WT) mice were from the same mouse colony as Thbs4 −/− mice or P387-TSP4-KI mice. For experiments exclusively using WT mice, WT C57BL/6 mice were purchased from the Jackson Laboratories. Animals were housed in the AAALAC-approved animal facilities of the Cleveland Clinic. Animal procedures were approved by y the Institutional Animal Care and Use Committee of the Cleveland Clinic and were in agreement with the NIH Guide for Animal Use.
LPS Induced peritonitis:
Mice were treated with intraperitoneal (IP) injection of Lipopolysaccharide (LPS, 0.5 μg/g, ThermoFisher) to induce peritonitis 72 hours prior to isolation of peritoneal cells by lavage and resection of visceral peritoneum. Mouse peritoneal macrophages (MPM) were used directly for cell adhesion and migration experiments. mRNA was isolated from MPM and peritoneal tissue. Immunofluorescence was also done on peritoneal tissues. IP injection with PBS was used for the control groups of animals.
Isolation and culture of primary macrophages:
Bone-marrow-derived macrophages (BMDM) were isolated from hind leg tibia and femur of WT, Thbs4 −/− or P387-TSP-4 KI mice. The bone marrow cells were collected and differentiated in to BMDM using 30 ng/mL M-CSF for 7 days. These cells were treated with 50 ng/mL GM-CSF, 50 ng/mL M-CSF, 40 ng/mL IL-4, 2000 IU/mL IFNγ, 0.5 μg/mL LPS. Following stimulations, cells were analyzed by western blot and quantitative RT-PCR for specific protein/gene expression patterns.
Cell Culture and Cell Lines:
Mouse macrophage cell line RAW 264.7 was purchased from ATCC (Virginia, USA). DMEM media (RAW 264.7) and grown in Eagle's Minimum Essential Medium (WBC264-9C) supplemented with 10% fetal bovine serum (FBS), sodium bi-carbonate (1.5gm/L), 100 U/mL penicillin, and 100 µg/mL streptomycin at 37 °C with 5% CO2 atmosphere according to ATCC recommendations. Cells were treated with 20 ng/mL GM-CSF (#NBP2-35066, Novus Biologicals), 20 ng/mL M-CSF (#14-8983-62, ThermoFisher), 40 ng/mL IL-4 (#574306, BioLegend), 1000 IU/mL IFNγ (#NBP2-35071, Novus Biologicals), 0.5 μg/mL lLipopolysaccharide (#00-4976-93, ThermoFisher), 25 μM cycloheximide (#0970, R&D Systems) dissolved in serum free DMEM. All RAW 264.7 cell experiments were done with cells between passage 4 and passage 8. Cells were exposed to a brief period of serum starvation in serum-free DMEM for 3 hours followed by stimulation with pro-inflammatory stimuli (LPS, GM-CSF, IFNγ), anti-inflammatory stimuli (M-CSF, IL-4) and cycloheximide (CHX) at above-mentioned doses for stated durations.
Western Blot Analysis:
Cells were harvested and lysed on ice using RIPA Lysis and Extraction Buffer (# 89901, Thermo Scientific) supplemented with Halt™ protease and phosphatase inhibitor cocktail (#78442, Thermo Scientific). Cell lysates were boiled with 2-Mercaptoethanol (#21985-023, LifeTechnologies) activated Laemmli Sample Buffer at 100 °C for 5 minutes. 50 mg of total protein was loaded in each well of 8% a Bis-Tris gel, run and transferred to PVDF blotting membrane using semi dry transfer module. After blocking with 5% skim milk in TBST for an hour at room temperature, membranes were probed overnight at 4 °C with primary antibodies [Anti TSP4 primary monoclonal Ab (#sc-390734, Santa Cruz Biotechnology) at 1:100 dilution; Anti β-Actin Ab (#A5316, Sigma-Aldrich) at 1:10000 dilution] followed by respective HRP anti-mouse antibody incubation and developed with Pierce® ECL Western Blotting Substrate on X-ray films
Quantitative real-time RT-PCR analysis:
Total RNA was extracted using TRIzol Reagent (#15596026, ThermoFisher) followed by cDNA synthesis using SuperScript™ First-Strand Synthesis System (#11904018, ThermoFisher). The TaqMan® probe for Thbs4 (Assay ID# Mm03003598_s1, ThermoFisher), CD68 (Assay ID# Mm03047343_m1, ThermoFisher), CD38 (Assay ID# Mm01220906_m1, ThermoFisher), Egr2 (Assay ID# Mm00456650_m1, ThermoFisher), Nos2 (Assay ID# Mm00440502_m1, ThermoFisher), Arg1 (Assay ID# Mm00475988_m1, ThermoFisher) were used for detecting respective genes expressions with Stx5a (Assay ID# Mm00502335_m1, ThermoFisher)) and ACTB (Assay ID# Mm02619580_g1, ThermoFisher) were used as housekeeping gene controls.
Macrophage differentiation and survival assays:
Cells were seeded in 24-well plates at 300,000 cells/well in M1 and M2 differentiation media (#C-28055, #C-28056, Promo Cell). Initial attachment of cells was determined after 3 hours using CyQUANT live cell quantification kits. Cells were kept into M1 and M2 differentiation media for 5 days followed by total live cell quantification using CyQUANT reagent. Each groups of live cell quantification after 5-day time-points were normalized to their respective 3 hours initial attachment quantification and compared to assess cell survival of macrophages from WT or Thbs4 −/− or P387-TSP4-KI mice.
BMDM Apoptosis Assay:
BMDM isolated from WT, Thbs4
−/− or P387-TSP-4-KI mice were differentiated with 50 ng/mL GM-CSF for 7 days. BMDM were treated with 0.5 μg/mL LPS in serum free media for 24 hours followed by qRT-PCR for Bax, Bcl2 and Caspase 3 (Casp3) expression.
For apoptosis assays, BMDM were seeded into 96-well plates (20,000 cells/well) and treated with 0.5 μg/mL LPS for 48 hours. Apoptosis was measured using Cell Meter™ No-Wash Live Cell Caspase 3/7 Activity Assay Kits (#20250, AAT Bioquest). Caspase 3/7 activity data were normalized to total number of live cells (determined by CyQUANT kit) in each of the respective experimental groups.
In vitro adhesion assays:
Adhesion assays were performed as previously described [14, 24, 25, 35, 37] . MPM were isolated from WT, Thbs4 −/− and P387-TSP4-KI mice 72 hours after treatment with 0.25µg/g LPS, and 5 × 10 3 cells were added for 1 hour at 37 °C to wells of 24-well plates (Corning) pre-coated with fibronectin (Sigma-Aldrich) or without coating.
In vitro migration assays:
MPM were isolated from LPS treated WT, Thbs4 −/− and P387-TSP4-KI mice, and 0.2 × 10 6 MPM were resuspended in the serum-free DMEM and transferred into the trans-well chambers (Corning, Corning, NY, USA). FBS (20%) was used as a chemo-attractant in the bottom chambers. The cells were incubated at 37 °C for 4 hours, the medium was aspirated, and attached cells were removed from the surface of the upper chamber using Q-tips. The plates were frozen at −80 °C for 3 hours, and DNA from remaining cells was quantified using CyQUANT reagent (Invitrogen, Carlsbad, CA, USA).
Immunohistochemistry, Immunofluorescence, confocal imaging and quantification of macrophage markers:
Sections of mice peritoneum were stained with primary rat anti-mouse CD68 antibody (MCA1957B, Bio-Rad), rabbit anti-mouse CD38 antibody (bs-0979R, Bioss Antibodies), Rabbit anti-mouse Egr2 (ab90518, Abcam) antibody using Vecta Stain ABC Kit. Visualization after staining with the antibodies was performed using a high-resolution slide scanner, Leica Aperio AT2 slide scanner (Leica Microsystems, GmbH, Wetzlar, Germany) was used to scan images of whole slides at 20x magnification and quantified to determine the percentage of the stained area using Adobe photoshop CS6 (Media Cybernetics). The person performing quantification was blinded to the assignment of animals between groups. For immunofluorescence, rat anti-mouse CD68 (MCA1957B, Bio-Rad), goat anti-human TSP4 (AF2390, R&D systems), were used with corresponding secondary antibodies (1:1000). Secondary antibodies were: anti-goat NL557 conjugated donkey IgG (NL001 R&D systems) and goat polyclonal antibody to rat IgG Alexa Fluor 488 (ab150161, abcam). Images were taken at a high-resolution confocal microscope (Leica DM 2500) at 63x magnification. All sections with primary antibodies were incubated for 2 hours at 4°C followed by incubating sections in secondary antibodies for 45 min at 4°C.
Statistical analysis:
Group size was calculated based on the previous data obtained in mouse models [5, 14, 24, 45] . Analyses of the data were performed using Sigma Plot Software (Systat Software, San Jose, CA, USA): Student's t-test and one-way ANOVA were used to determine the significance of parametric data, and Wilcoxon rank sum test was used for nonparametric data. The significance level was set at p=0.05. The data are presented as mean ± SEM, number of biological repeats are listed in each legend.
Results
LPS and pro-inflammatory cytokines induce TSP-4 expression in macrophages:
LPS induced TSP4 in a time-dependent manner in RAW264.7 and BMDM (Fig.1A) . Most TSP-4 was intracellular in both macrophage types (Fig. 1B) . In both cell types, both the protein levels and mRNA levels were increased in response to LPS stimulation of cells (Fig. 1A and C) . The decreases in protein levels in cells treated with cycloheximide were comparable to untreated cells, also consistent with the transcriptional mechanism or increased RNA stability.
We examined the effects of pro-inflammatory (LPS, IFNγ, and GM-CSF) and anti-inflammatory stimuli (M-CSF and IL-4) on the levels of TSP-4 protein and mRNA in RAW 264.7 cells (Fig. 2 ) and in BMDM (Fig.3 ). BMDM were isolated from mice and cultured in macrophage differentiation media for 7 days. The purity was assessed by flow cytometry using anti-CD11b and F4/80 staining and was 93-98% (Suppl. Fig.1 ). Western blot analysis showed a gradual increase in TSP-4 protein levels with pro-inflammatory stimuli LPS, IFNγ and GM-CSF. Conversely, TSP-4 protein levels reduced with anti-inflammatory cytokine IL-4 and M-CSF stimulation ( Fig. 2A and B; Fig.3A ). Average TSP-4 protein amount was quantified from three independent experiments and normalized to β Actin expression as a loading control. Antiinflammatory stimuli caused significant (*p<0.05) reduction in TSP-4 protein levels ( Fig. 2A and B, Fig.3A and B).
THBS4 mRNA levels was measured by quantitative RT-PCR ( Fig.2C and 3C ). There was significant (*p<0.05) increase in THBS4 expression upon stimulation with pro-inflammatory stimuli and a decrease in THBS4 expression with anti-inflammatory stimuli.
Expression of markers of both pro-inflammatory (CD38 and Nos2, Suppl. Fig. 2 ) and tissuerepair (Egr2 and Arg1, Suppl. Fig. 3 ) macrophages was measured in RAW 264.7 cells and BMDM treated. Following stimulation with IFNγ (1000IU/mL), GM-CSF (20ng/mL), LPS (0.5μg/mL), M-CSF (20ng/mL) or IL-4 (40ng/mL), increased TSP-4 levels were detected and correlated with increased CD38 and Nos2 expression and a decrease in Egr2 and Arg1 expression. Decrease in TSP-4 levels was associated with decreased CD38 and Nos2 expression and increased Egr2 and Arg1 expression.
TSP-4 promotes differentiation of macrophages into pro-inflammatory phenotype:
To understand whether TSP-4 promotes the differentiation of macrophages into proinflammatory phenotype or whether the increased production of TSP-4 results from differentiation but does not affect the process, BMDM from WT and Thbs4 -/-mice were stimulated with LPS (0.5 μg/mL) and IFNγ (1000 IU/mL), and the levels of mRNA of the markers of pro-inflammatory differentiation of macrophages CD38 and Nos2 were measured by RealTime PCR (Fig.4) . The levels of both markers were significantly decreased in BMDM from Thbs4 -/-mice, suggesting that TSP-4 promotes the differentiation into proinflammatory phenotype.
TSP-4 regulates the survival of pro-inflammatory macrophages:
Programmed death is a natural fate of pro-inflammatory macrophages and is associated with release of inflammatory signals [46] [47] [48] [49] [50] [51] [52] [53] . Knowing that TSP-4 expression promotes proinflammatory phenotype of macrophages, we investigated the effect of TSP-4 on cultured macrophage apoptosis.
When BMDM from WT, Thbs4 -/-, and P387-TSP4-KI mice were differentiated in proinflammatory (M1) medium or tissue repair differentiation (M2 medium), the survival of cultured pro-inflammatory BMDM but not tissue repair BMDM was increased in the Thbs4 -/-cells and decreased in P387-TSP4-KI cells (Fig. 5A ).
Monocytes were isolated from mouse blood and differentiated in M1 or M2 media. In M1 or M2 media, lack of TSP-4 resulted significantly higher survival of cells, but P387-TSP-4 did not affect cell number (Fig. 5B) .
TSP-4 promotes apoptosis in pro-inflammatory macrophages:
Expression of Bax, Bcl2, Casp3 and the activity of Caspase 3/7 were measured in BMDM differentiated into pro-inflammatory macrophages (Fig. 5C, D) . Lower apoptotic activity was detected in Thbs4 -/-cells as indicated by decreased Bax/Bcl2 ratio, decreased expression of Casp3, and activity of Caspase 3/7 (Fig.5C) . In contrast, the activity of Caspase 3/7 was upregulated in response to LPS in P387-TSP4-KI BMDM (Fig.5D ). This differential effect is consistent with the higher activity of P387-TSP4 in other cellular responses [24, [35] [36] [37] .
Macrophages in peritoneal cavity and tissue of mice with LPS-induced peritonitis:
To evaluate the expression and the effect of TSP-4 on macrophages in a model of acute inflammation, we induced peritonitis in WT, Thbs4 -/-, and P387-TSP4-KI mice by IP injection of LPS. Mice were sacrificed 72 hours later, and cells (> 90%) macrophages) were collected by peritoneal lavage and quantified (Fig. 6A) . Surprisingly, TSP4 deletion in the Thbs4 -/-mice did not reduce the number of macrophages recovered in a saline lavage (free macrophages) compared to WT mice, but we collected fewer macrophages from the cavity of P387-TSP4-KI mice than from WT mice after LPS-induced peritonitis (Fig. 6A) . To find out whether the LPSinduced inflammation affects the expression of TSP-4 in peritoneal tissues and in free macrophages, we assessed the levels of Thbs4 mRNA (Fig.6B) . TSP-4 expression was dramatically decreased in free peritoneal macrophages and significantly increased in peritoneal tissue of WT mice, suggesting that high levels of TSP-4 in tissue and in macrophages may promote their accumulation in the peritoneal tissue and/or prevent their egress into the cavity.
Immunofluorescence with anti-CD68 and anti-TSP-4 antibodies revealed that TSP-4 protein is associated with macrophages in peritoneal tissue in both WT and P387-TSP4-KI mice (Fig. 6C ).
There were no significant changes in monocyte counts in the blood from the two transgenic mice (Suppl. Fig. 4 ).
TSP4 increases the number of pro-inflammatory macrophages in peritoneal tissue:
Expression of CD68, a marker of macrophages, was upregulated in peritoneal tissues of WT (Fig.7A ) and even more dramatically in Thbs4 -/- (Fig.7B ) mice with LPS-induced peritonitis. TSP4 deficiency resulted in higher accumulation of macrophages in peritoneal tissues. In a view of a lack of differences in numbers of macrophages in peritoneal cavity (Fig.6A ) and the equal numbers of macrophages in blood (Suppl. Fig.4) , this suggested the effect of TSP4 on macrophage survival in tissues, consistent with our observations in cultured macrophages. The expression of the marker of pro-inflammatory macrophages CD38 was upregulated in both WT and Thbs4 -/-mice ( Fig.7A and B) , but the expression of Egr2, a marker of tissue-repair macrophages, was decreased (Fig. 7A) , suggesting that most macrophages retained in the peritoneal tissue are pro-inflammatory. Consistent with the difference between WT and Thbs4 -/-mice and the P387-TSP4, P387-TSP4 reduced the accumulation of macrophages in peritoneal tissue (Fig.7C) , suggesting more profound effect on their survival.
P387 TSP-4 is more active in supporting the adhesion of monocytes and macrophages:
We used murine macrophage-like cell line RAW264.7 to assess the effect of A387 TSP-4 and P387 TSP-4 on macrophage adhesion and migration (Fig.7) . RAW264.7 cells migrated less on rTSP-4 as a substrate, and P387 TSP-4 further decreased their migration (Fig.7A) . RAW264.7 adhered significantly better to P387 TSP-4 (Fig.7B) , although both A387 and P387 TSP-4 supported the adhesion of macrophage-like cells.
Discussion
High expression of TSP4 in remodeling tissues, particularly in heart disease and cancer [5] [6] [7] [8] [9] [10] [11] [12] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , suggested that this matricellular protein may regulate fibrosis and angiogenesis. The effects of TSP-4 on matrix remodeling has been demonstrated in Thbs4 -/-mice by us and others [5] [6] [7] 45] , and we recently reported that TSP4 is pro-angiogenic [24, 25] in contrast to the prominent role of TSP-1 as an anti-angiogeneic protein [2, 54, 55] . Tissue remodeling is associated with inflammation, and we reported that TSP4 deficiency results in reduced inflammation in atherosclerotic lesions in ApoE -/-mice: the number of macrophages in the atherosclerotic lesion and the local vascular inflammation were reduced in Thbs4 -/-/ApoE -/-mice [14] . To investigate the roles of TSP4 and its variants in inflammation, we examined the effects of TSP-4 on cultured macrophages and on macrophages in an LPS-induced mouse peritonitis model.
Several agents that are known to promote pro-inflammatory differentiation of macrophages [LPS, GM-CSF, and INFg [56] ] or tissue-repair differentiation [IL-4 [56] and M-CSF [57] ] were used to stimulate cultured RAW264.7 or BMDM. LPS that was also used to induce peritonitis increased TSP-4 production by macrophages in a time-dependent manner. mRNA of Thbs4 was also upregulated, and production of the protein was efficiently blocked by cycloheximide, suggesting transcriptional regulation or reduced RNA stability. The newly synthesized protein accumulated in vesicle-like structures inside the cells and was not efficiently secreted into the medium or matrix (not shown). Intra-cellular functions have been reported for TSPs [7] . Finding of increased amounts of intracellular TSP4 suggests that such intracellular functions of TSP4 may be activated by the treatment or that macrophages accumulate protein in vesicles that may be released in specific tissues where an inflammation response has been triggered.
All pro-inflammatory signals that resulted in pro-inflammatory differentiation with increased expression of CD38 and Nos2 (markers of pro-inflammatory macrophages) and decreased expression of Egr-2 and Arg1 (markers of tissue repair macrophages) also increased TSP-4 expression and production. To the contrary, anti-inflammatory signals promoting the tissue repair differentiation of macrophages (decreased CD38 and Nos2 and increased Egr-2 and Arg1) decreased the expression of Thbs4 and the production of the TSP4 protein. Thus, our results suggested a novel role for TSP-4 in inflammation: support of pro-inflammatory functions of macrophages. When BMDM from Thbs4 -/-mice were stimulated with pro-inflammatory signals, the levels of markers of pro-inflammatory macrophages were decreased, demonstrating that TSP-4 actively promotes macrophage differentiation into pro-inflammatory phenotype.
We analyzed cultured primary BMDM and blood monocytes and found that survival of both cell types was higher in Thbs4 -/-macrophages cultured in M1 medium. P387-TSP4 in macrophages from P387-TSP4KI mice significantly decreased their survival. Knowing that TSP-4 expression is associated with pro-inflammatory macrophages, we hypothesized that the regulation of macrophage number in peritonitis model may be associated with their ability to differentiate into the pro-inflammatory phenotype and to commit to apoptosis, a process closely associated with pro-inflammatory differentiation. Pro-inflammatory macrophages produce and release inflammatory stimuli, and this release is associated with their transition to apoptosis [46] [47] [48] [49] [50] [51] [52] [53] . Both our in vivo and in vitro results suggested that TSP4 is needed for completion of proinflammatory differentiation of macrophages, their transition into apoptosis and their release of pro-inflammatory signals. This sequence of events was observed using cultured RAW264.7 and BMDM. TSP-4 KO reduced caspase 3 gene expression and activity of caspase 3/caspase 7, as well as the ratio of expressed Bax/Bcl2 in BMDM in response to LPS stimulation, confirming that TSP-4 promotes apoptosis in pro-inflammatory macrophages. P387 TSP-4 BMDM from P387-TSP4-KI mice had increased expression of apoptotic markers compared to BMDM isolated from WT mice, consistent with higher activity of this TSP-4 variant in many cellular effects and interactions that we previously reported.
TSP4 increased accumulation of macrophages in peritoneal tissues, presumably by increasing their adhesive properties and reducing the macrophage migration as was demonstrated in cultured cells. LPS injection significantly increased the number of macrophages recovered in the lavage of the peritoneal cavity of WT mice and Thbs4 -/-mice, but, in P387-TSP4-KI mice, the number of recovered macrophages was not increased by LPS compared to the saline control. Peritoneal macrophages in the lavage produced very little TSP4, while the levels of TSP4 mRNA and protein were increased in peritoneal tissue as was detected by QRT-PCR and immunofluorescence. TSP4 production was associated with CD68 positive cells, macrophages, in the tissue. The production of TSP4 by the blood cells has not been previously reported, and the ability of macrophages to produce TSP4 protein has not been recognized. However, as we report here, we identified several proinflammatory agonists that stimulate macrophages to produce TSP4 both in cell culture and in vivo.
P387-TSP4 is a SNP variant of TSP4 that is carried by >30% of North American population [18] . In our previous studies of this TSP4 variant in vitro in cell culture, and in vivo in a mouse model, we found that P387-TSP4 was more active in all cellular effects and interactions tested and was is less susceptible to proteolytic degradation [5, 14, 24, 25, [35] [36] [37] 45] . Thus, the lack of increased macrophage egress into the peritoneal cavity of P387-TSP4-KI mice was surprising and suggested that P387-TSP4 prevented macrophage egress from tissues leading to increased accumulation in peritoneal tissues due to its higher adhesive properties than the WT, A387-TSP4 form.
TSP4 supports the adhesion of leukocytes [14, 35] , and macrophages specifically [14] . We have performed adhesion and migration assays with macrophage-like cells RAW264.7 and demonstrated that both A387-and P387-TSP4 support the adhesion of macrophages and reduce their migratory activity, but, as was expected based on our previous publications [24, [35] [36] [37] , P387-TSP4 is more effective in these functions.
Although the accumulation of macrophages in peritoneal tissue was increased in response to LPS in all three mouse strains, WT expressing the A387-TSP4 isoform, Thbs4 -/-, and P387-TSP4-KI, the relative increase in macrophage accumulation (in comparison to mice receiving PBS) was surprisingly higher in Thbs4 -/-mice and significantly lower in P387-TSP4-Ki mice. Since the number of monocytes in blood was not significantly different between the three genotypes, and the number of macrophages in peritoneal cavity could not account for any differences in macrophage accumulation in tissues, these results suggested that TSP4 levels might affect survival of macrophages in tissues. In addition to the effect of TSP4 on CD68 levels, CD38 levels also followed the trend, suggesting that TSP4 acts on pro-inflammatory macrophages rather than tissue repair macrophages. Similar to other TSP4 functions, the P387 variant of TSP4 was more active in exerting these effects on macrophages, promoting inflammation, accumulation of macrophages in tissue, and their transition to apoptosis that allows macrophages to release pro-inflammatory stimuli and sustain a pro-inflammatory environment.
The association of TSP4 with tissue inflammation and pro-inflammatory differentiation of macrophages was observed in vivo, in peritonitis model, as well as in cultured macrophages. TSP-4 carries out a dual role in inflammation by facilitating macrophage adhesion and promoting the pro-apoptotic response of macrophages at sites of tissue inflammation. This association suggests a new and unanticipated role for TSP-4 in inflammation: TSP4 and its P387 variant are produced by macrophages in response to inflammatory stimuli and regulate the accumulation of macrophages in tissues and their pro-inflammatory functions. A: Bone-marrow-derived macrophages (BMDM) from WT, KO, and KI mice were differentiated in culture in M1 or M2 differentiation media, and the number of survived cells (number of cells on day 5/number of cells 3 hour after seeding) was measured using the CyQuant cell survival assay kit; n=5; *p<0.05. B: Purified mouse blood monocytes were differentiated in M1 or M2 differentiation cell culture media, and the number of survived cells was measured; n=12; *p<0.05. C: Bone-marrow-derived macrophages (BMDM) were differentiated in M1 differentiation medium for 7 days and stimulated with LPS for 48 hours. The expression of Bax, Bcl2, and Casp3 and the activity of Caspase 3/7 enzymes were measured in cultured BMDM from WT and Thbs4 -/-mice; n = 3; *p < 0.05. D: The activity of Caspase 3/7 enzymes was measured in cultured BMDM from WT and P387-TSP4-KI mice; n = 3; *p < 0.05. Expression of CD68 and CD38 was measured in peritoneal tissues of Thbs4 -/-mice with LPSinduced peritonitis; n=3; *p<0.05. C: Expression of CD68 and CD38 was measured in peritoneal
